Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, April 23, 2025

View Back issues

Consumer Law

A federal judge declined to certify a class, but <a href="http://www.courthousenews.com/wp-content/uploads/2019/07/Consumer-Law.pdf"><strong>denied Pfizer’s request</strong></a> for summary judgment on claims it charged more for Maximum Strength Robitussin cough syrup than for Regular Strength Robitussin when the former had a lower concentration of active ingredients than the latter.

CHICAGO — A federal judge declined to certify a class, but denied Pfizer summary judgment on claims it charged more for Maximum Strength Robitussin cough syrup than for Regular Strength Robitussin, when the former had a lower concentration of active ingredients than the latter.

Categories / Business, Consumers

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

Loading...